Patent · US Active

Rapaglutins, novel inhibitors of GLUT and use thereof

US11708391B2 · kind B2 · utility

0Cited by

18References

4Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Jun O. Liu · Clarksville, US
Jingxin Wang · Baltimore, US
Zufeng Guo · Baltimore, US

Key dates

Filing date	Feb 3, 2017
Grant date	Jul 25, 2023
Priority date	—
Expiry date	Aug 7, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds with the following structures and their analogs are provided. Compositions that include these structures can be used to inhibit glucose transporters and stop or decrease the proliferation of cancer, treat possible organ rejection and treat autoimmune disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.